Related Experiment Video
Updated: Feb 15, 2026

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural
Sujing Jiang1, Guannan Wang, Ying Dong
1Department of Medical Oncology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Rationale:
Angiogenesis is a key factor for tumor growth and metastasis both in cancer and sarcoma. Endostar, a novel safe and well-tolerated recombinant human endostatin, can suppress the expression of VEGF and the activation of ERK, MAPK, and AKT, and then inhibit tumor progression.
Patient Concerns:
A pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion.
Diagnoses:
Osteosarcoma with pulmonary metastasis and malignant pleural effusion.
Interventions:
Considering the physical condition of patient, the patient underwent surgical resection of the right lung lesion after receiving endostar combined with chemotherapy and maintained endostar alone for 47 cycles.
Outcomes:
The patient obtained pathologic complete remission and had been in progression-free survival up to now.
Lessons:
Our experience could provide a treatment strategy for pediatric osteosarcoma patients with pulmonary metastasis and malignant pleural effusion.
Insights
Endostar, a recombinant human endostatin, effectively treated a pediatric osteosarcoma case with metastasis. The patient achieved complete remission and remains progression-free, suggesting a potential new treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Angiogenesis is crucial for tumor growth and metastasis in cancers and sarcomas.
- Endostar (recombinant human endostatin) is a novel therapeutic agent that inhibits tumor progression by suppressing VEGF and key signaling pathways like ERK, MAPK, and AKT.
Observation:
- A pediatric patient diagnosed with osteosarcoma presented with pulmonary metastasis and malignant pleural effusion.
- The patient's condition necessitated a tailored treatment approach due to their physical state.
Findings:
- The patient received a combination of Endostar and chemotherapy, followed by Endostar monotherapy for 47 cycles.
- This treatment regimen resulted in a pathologic complete remission.
- The patient has maintained progression-free survival to date.
Implications:
- This case highlights Endostar's potential as a viable treatment strategy for pediatric osteosarcoma with extensive metastasis.
- The findings suggest Endostar could be a valuable option for managing complex cases involving pulmonary and pleural involvement.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Pleural Disorders: Types and Brief Description
Data Reporting and Recording

